Brellium · 2 days ago
Business Development Representative
Brellium is a health-tech startup focused on improving the standard of care in the U.S. healthcare system through AI-powered technology. The Business Development Representative will drive growth by prospecting and generating new business opportunities while collaborating with the sales and marketing teams.
Artificial Intelligence (AI)BillingEnterprise SoftwareSaaS
Responsibilities
Identify and qualify leads through outbound prospecting (email, phone, social media) to build a solid pipeline
Research target accounts and reach out to decision-makers in healthcare clinics, including C-suite executives
Collaborate with the Account Executive team to schedule meetings, demos, and follow-up conversations
Assist in refining our outreach and sales processes to optimize conversion rates
Build and maintain strong relationships with prospects to understand their pain points and how Brellium can help solve them
Track outreach efforts and sales activities using CRM tools
Participate in team discussions, bringing new ideas to improve the sales strategy and process
Qualification
Required
A strong desire to grow your career in sales and learn about the healthcare and AI industries
A proactive and organized approach to work with a passion for hitting and exceeding targets
Excellent verbal and written communication skills
A positive attitude, resilience, and creativity in problem-solving
Preferred
Previous experience in a B2B sales development or customer-facing role is a plus, but not required
Benefits
401(k) Retirement Savings Plan
Equity Compensation
Dinner Provided via DoorDash & stocked kitchen for NY employees
Medical, Dental, and Vision coverage
HSA / FSA
11 paid holidays each year
Unlimited PTO
Training and professional development
Hybrid Work Schedule (4 days onsite, 3 if located > 1 hour away)
Company
Brellium
Brellium is an AI-powered clinical note auditor that conducts note audits according to customized clinical and billing standards.
Funding
Current Stage
Growth StageTotal Funding
$27.84MKey Investors
First Round Capital
2025-03-17Series A· $16.7M
2024-11-05Series A· $11.14M
2022-08-01Seed
Recent News
Behavioral Health Business
2025-07-10
Behavioral Health Business
2025-04-23
Company data provided by crunchbase